Based on molecular markers, including estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), BC is categorized into three major subtypes: hormone receptor (HR)-positive, HER2-positive, and triple-negative breast cancer (TNBC). Here, PGR is linked to breast cancer.